 | Up a level |
von Moos, R; Seifert, B; Simcock, M; Goldinger, S M; Gillessen, S; Ochsenbein, A; Michielin, O; Cathomas, R; Schläppi, M; Moch, H; Schraml, P H; Mjhic-Probst, D; Mamot, C; Schönewolf, N; Dummer, R; Swiss Group for Clinical Cancer Research, (SAKK) (2012). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Annals of oncology, 23(2), pp. 531-6. Oxford: Oxford University Press 10.1093/annonc/mdr126
Roos, J; Hennig, I; Schwaller, J; Zbären, J; Dummer, R; Burg, G; Tobler, A; Virgilio, L; Croce, CM; Fey, MF; Borisch, B (2001). Expression of TCL1 in hematologic disorders. Pathobiology, 69(2), pp. 59-66. Basel: Karger 10.1159/000048758
